TSI Health Sciences announced today the launch of PromilinPro®, a patented and highly concentrated Fenugreek extract standardized 60% 4-Hydroxyisoleucine (4-HI).
According to Larry Kolb, TSI US operations president, PromilinPro®, with one issued and three pending patents, allows customers enhanced flexibility to incorporate the highest level of 4-HI into formulations to achieve a daily efficacious dose. Like Promilin® (with 20% 4-HI), PromilinPro® is a matrix of amino acids that work in synergy with 4-HI.
All of the clinical studies conducted to date are specific to the unique and proprietary footprint from Fenugreek. Studies show the Promilin® line of ingredients significantly increase the rate of post-exercise muscle glycogen resynthesis by 63% when compared to placebo in trained male cyclists. Promilin® helps to improve endurance during aerobic training by sustaining glycogen stores. Also, 4-Hydroxyisoleucine is proven to have a direct effect on the enhancement of insulin sensitivity in humans.
“This development has created a tremendous opportunity for added value to our customer’s products. There is growing enthusiasm in the marketplace for this ingredient and we anticipate major brands will be adding PromilinPro® to their new or existing products soon,” Kolb said.
For more information contact TSI Health Sciences, Inc. customer services at www.TSIInc.com or call toll-free 877.549.9123.
About TSI Health Sciences
TSI Health Sciences, www.TSIInc.com, is a leading developer, producer and marketer of fine chemical ingredients used by the dietary supplement, pharmaceutical and food and beverage industries. With US operations based in Missoula, Montana, TSI was founded in 1996 and has sales and marketing offices worldwide, including a 60-acre, fully integrated manufacturing, research, quality assurance and quality control campus in Jiangyin, China. The company’s specialized product range includes performance- based branded ingredients that are derived from botanical and natural product extracts, fermentation, and highly purified synthesis. TSI manufacturers its ingredients to the highest global standards, ICH Q7A international CGMP manufacturing guidelines.